194 related articles for article (PubMed ID: 32994401)
21. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain.
Felsky D; Patrick E; Schneider JA; Mostafavi S; Gaiteri C; Patsopoulos N; Bennett DA; De Jager PL
Mol Neurodegener; 2018 Jul; 13(1):38. PubMed ID: 30041668
[TBL] [Abstract][Full Text] [Related]
22. Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies.
van der Lee SJ; van Steenoven I; van de Beek M; Tesi N; Jansen IE; van Schoor NM; Reinders MJT; Huisman M; Scheltens P; Teunissen CE; Holstege H; van der Flier WM; Lemstra AW
J Alzheimers Dis; 2021; 83(1):269-279. PubMed ID: 34308904
[TBL] [Abstract][Full Text] [Related]
23. Dissociable influences of
Ge T; Sabuncu MR; Smoller JW; Sperling RA; Mormino EC;
Neurology; 2018 May; 90(18):e1605-e1612. PubMed ID: 29592889
[TBL] [Abstract][Full Text] [Related]
24. Polygenic risk associated with Alzheimer's disease and other traits influences genes involved in T cell signaling and activation.
Dressman D; Tasaki S; Yu L; Schneider J; Bennett DA; Elyaman W; Vardarajan B
Front Immunol; 2024; 15():1337831. PubMed ID: 38590520
[TBL] [Abstract][Full Text] [Related]
25. Associations of risk genes with onset age and plasma biomarkers of Alzheimer's disease: a large case-control study in mainland China.
Jiao B; Xiao X; Yuan Z; Guo L; Liao X; Zhou Y; Zhou L; Wang X; Liu X; Liu H; Jiang Y; Lin Z; Zhu Y; Yang Q; Zhang W; Li J; Shen L
Neuropsychopharmacology; 2022 Apr; 47(5):1121-1127. PubMed ID: 35001095
[TBL] [Abstract][Full Text] [Related]
26. Transferability of Alzheimer Disease Polygenic Risk Score Across Populations and Its Association With Alzheimer Disease-Related Phenotypes.
Jung SH; Kim HR; Chun MY; Jang H; Cho M; Kim B; Kim S; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Jang JW; Kim Y; Hong JY; Choi SH; Noh Y; Kim KW; Kim SE; Lee JS; Jung NY; Lee J; Lee AY; Kim BC; Cho SH; Cho H; Kim JH; Jung YH; Lee DY; Lee JH; Lee ES; Kim SJ; Moon SY; Son SJ; Hong CH; Bae JS; Lee S; Na DL; Seo SW; Cruchaga C; Kim HJ; Won HH
JAMA Netw Open; 2022 Dec; 5(12):e2247162. PubMed ID: 36520433
[TBL] [Abstract][Full Text] [Related]
27. Centenarian controls increase variant effect sizes by an average twofold in an extreme case-extreme control analysis of Alzheimer's disease.
Tesi N; van der Lee SJ; Hulsman M; Jansen IE; Stringa N; van Schoor N; Meijers-Heijboer H; Huisman M; Scheltens P; Reinders MJT; van der Flier WM; Holstege H
Eur J Hum Genet; 2019 Feb; 27(2):244-253. PubMed ID: 30258121
[TBL] [Abstract][Full Text] [Related]
28. Effect of Pathway-specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals.
Xu Y; Vasiljevic E; Deming YK; Jonaitis EM; Koscik RL; Van Hulle CA; Lu Q; Carboni M; Kollmorgen G; Wild N; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Engelman CD
medRxiv; 2023 Feb; ():. PubMed ID: 36778431
[TBL] [Abstract][Full Text] [Related]
29. Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study.
Ahmad S; Bannister C; van der Lee SJ; Vojinovic D; Adams HHH; Ramirez A; Escott-Price V; Sims R; Baker E; Williams J; Holmans P; Vernooij MW; Ikram MA; Amin N; van Duijn CM
Alzheimers Dement; 2018 Jul; 14(7):848-857. PubMed ID: 29494809
[TBL] [Abstract][Full Text] [Related]
30. Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging.
Kauppi K; Rönnlund M; Nordin Adolfsson A; Pudas S; Adolfsson R
Transl Psychiatry; 2020 Jul; 10(1):250. PubMed ID: 32709845
[TBL] [Abstract][Full Text] [Related]
31. Association of Cognitive Function Trajectories in Centenarians With Postmortem Neuropathology, Physical Health, and Other Risk Factors for Cognitive Decline.
Beker N; Ganz A; Hulsman M; Klausch T; Schmand BA; Scheltens P; Sikkes SAM; Holstege H
JAMA Netw Open; 2021 Jan; 4(1):e2031654. PubMed ID: 33449094
[TBL] [Abstract][Full Text] [Related]
32. The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia.
Tasaki S; Gaiteri C; Mostafavi S; De Jager PL; Bennett DA
Front Neurosci; 2018; 12():699. PubMed ID: 30349450
[TBL] [Abstract][Full Text] [Related]
33. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Alzheimer's Disease-Associated Genetic Variants on Longevity.
Tesi N; Hulsman M; van der Lee SJ; Jansen IE; Stringa N; van Schoor NM; Scheltens P; van der Flier WM; Huisman M; Reinders MJT; Holstege H
Front Genet; 2021; 12():748781. PubMed ID: 34992629
[TBL] [Abstract][Full Text] [Related]
35. Characterization of brain resilience in Alzheimer's disease using polygenic risk scores and further improvement by integrating mitochondria-associated loci.
Xu X; Wang H; Bennett DA; Zhang QY; Meng XY; Zhang HY
J Adv Res; 2024 Feb; 56():113-124. PubMed ID: 36921896
[TBL] [Abstract][Full Text] [Related]
36. Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease.
Patel T; Brookes KJ; Turton J; Chaudhury S; Guetta-Baranes T; Guerreiro R; Bras J; Hernandez D; Singleton A; Francis PT; Hardy J; Morgan K
Neuropathol Appl Neurobiol; 2018 Aug; 44(5):506-521. PubMed ID: 29181857
[TBL] [Abstract][Full Text] [Related]
37. APOE ɛ4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals.
Håglin S; Koch E; Schäfer Hackenhaar F; Nyberg L; Kauppi K
Sci Rep; 2023 May; 13(1):8433. PubMed ID: 37225733
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease.
Paliwal D; McInerney TW; Pa J; Swerdlow RH; Easteal S; Andrews SJ;
Neurobiol Aging; 2021 Dec; 108():213-222. PubMed ID: 34521561
[TBL] [Abstract][Full Text] [Related]
39. Protective genes and pathways in Alzheimer's disease: moving towards precision interventions.
Seto M; Weiner RL; Dumitrescu L; Hohman TJ
Mol Neurodegener; 2021 Apr; 16(1):29. PubMed ID: 33926499
[TBL] [Abstract][Full Text] [Related]
40. How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer's disease risk? A novel integrative model.
de Frutos Lucas J; Sewell KR; García-Colomo A; Markovic S; Erickson KI; Brown BM
Alzheimers Res Ther; 2023 Jan; 15(1):22. PubMed ID: 36707869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
